By Professor David Lawson Morris

Conference Presentations

Saxena A; Morris DL, 2010, 'Clinicopathologic and treatment-related factors influencing recurrence and survival after hepatic resection of intrahepatic cholangiocarcinoma: A 19-year experience form an Established Australian Hepatobiliary', presented at Annuals Scientific Congress, Perth Convention Exhibition Centre, Perth, Australia, 04 May 2010 - 07 May 2010

Morris DL, 2010, 'Evaluation of the effectiveness of a novel anaesthetic protocol in reducing massive blood transfusion during cytoreductive surgery: Can early and aggressive administration of fresh frozen plasma combined with restrictive fluid resuscitation really work?', presented at Annuals Scientific Congress, Perth Convention Exhibition Centre, Perth, Australia, 04 May 2010 - 07 May 2010

Morris DL, 2010, 'Progression and survival results following radical hepatic metastasectomy of advanced neuroendocrine tumor supports and aggressive surgical approach', presented at Annuals Scientific Congress, Perth Convention Exhibition Centre, Perth, Australia, 04 May 2010 - 07 May 2010

Pourgholami MH; Cai YZ; Badar S; Poruchynsky MS; Morris DL, 2010, 'Down-regulation of tumoral hypoxia-inducible factor-1 alpha expression in OVCAR-3 tumors by albendazole', presented at AACR 101st Annual Meeting, Walter E.Washington Convention Centre, Washington DC, 17 April 2010 - 21 April 2010

Chua TC; Saxena A; Chu F; Liauw WS; Kokandi A; Zhao J; Morris DL, 2010, 'Clinicopathological determinants of survival after hepatic resection on hepatocellular cacinoma in 97 patients - Experience from an Australia Hepatobiliary Unit', presented at 63rd Annual Cancer Symposium, Society of Surgical Oncology, St. Louis, Missouri, 03 March 2010 - 07 March 2010

Chua TC; Chu F; Butler P; Quinn RJ; Glenn DW; Morris DL, 2010, 'Intra-arterial iodine-131-lipiodol for unresectable hepatocellular carcinoma', presented at 63rd Annual Cancer Symposium, Society of Surgical Oncology, St. Louis, Missouri, 03 March 2010 - 07 March 2010

Morris DL, 2009, 'Peritonectomy for colorectal cancer, pseudomyxoma peritonei peritoneal mesothelioma and ovarian cancer', presented at 5th Scientific Conference for Saudi General Surgery Society, King Fahad Medical Research Centre, King Abdulaziz University Jeddah, 19 October 2009 - 21 October 2009

Chua TC; Liauw WS; Saxena A; Chu F; Glenn DW; Chai A; Morris DL, 2009, 'Systematic review of randomized and nonrandomized trials on the clinical efficacy and safety of neoadjuvant transarterial chemoembolization (TACE)for resectable hepatocellular carcinoma', presented at International Liver Cancer Association 3rd Annual Conference (ILCA), Milan, Italy, 04 September 2009 - 06 September 2009

Maunic M; Morris DL, 2009, 'Colon cancer', presented at Medical Legal Conference, Amora Hotel, Jamison Street, Sydney Australia, 24 July 2009

Saxena A; Morris DL, 2009, 'Preoperative and operative risk factors for complications after cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei', presented at Royal Australasian College of Surgeons Annual Scientific Congress, Brisbane, Australia, 06 May 2009

Saxena A; Morris DL, 2009, 'Risk factors for massive blood transfusion after cytoreductive surgery and perioperative intraperitoneal chemotherapy', presented at Royal Australasian College of Surgeons Annual Scientific Congress, Brisbane, Australia, 06 May 2009

Morris DL, 2009, 'Peritonectomy role in advanced/recurrent ovarian cancer', presented at 1st International Conference & Workshop on Up to Date Obstetrics & Gynecology, King Fahad Medical City, Riyadh, 13 April 2009 - 15 April 2009

Morris DL, 2009, 'Cytoreductive surgery', presented at National Symposium on Update of Oncology & Lymphoma, King Fahad Specialist Hospital Buraidah, Al Qassim & Prince Faisal Bin Bandar Cancer Centre, 08 April 2009

Chua TC; Yao P; Akhter J; Young L; Samaraweera U; Yan TD; Morris DL, 2009, 'Differential expression of Ki-67, estrogen receptor, and progesterone receptor between genders in peritoneal mesothelioma: An immunohistochemistry study that provides a plausible explanation for the better prognosis in females?', presented at Annual Cancer Symposium Society of Surgical Oncology, Phoenix Arizona, USA, 04 March 2009 - 08 March 2009

Conference Abstracts

Kozman MA; Fisher OM; Liauw W; Morris DL, 2023, 'ASO Visual Abstract: Use of Prognostic Factors and Scores in Selection of Patients with Colorectal Cancer Peritoneal Metastasis (CRPM) for Cytoreductive Surgery and Intraperitoneal Chemotherapy (CRS/IPC): Results of an International Survey Among Oncologic Clinicians', in Annals of surgical oncology, Vol. 30, pp. 3346 - 3347, http://dx.doi.org/10.1245/s10434-022-12857-7

Karpes J; Dotta D; Fisher O; Shamavonian R; Alzahrani N; Morris DL, 2019, 'Prognostic value of the volume time index (VTI) ratio for patients with appendiceal cancer with peritoneal carcinomatosis treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC).', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, IL, Chicago, Vol. 37, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 31 May 2019 - 04 June 2019, http://dx.doi.org/10.1200/JCO.2019.37.15_suppl.e15704

Ataie-Kachoie PA; Akhter J; Morris DL, 2015, 'Monepantel a new first in class potent inhibitor of P70S6K potentiates the anti-tumor effects of gemcitabine and doxorubicin: In vitro and in vivo studies', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, PA, Philadelphia, Vol. 75, presented at 106th Annual Meeting of the American-Association-for-Cancer-Research (AACR), PA, Philadelphia, 18 April 2015 - 22 April 2015, http://dx.doi.org/10.1158/1538-7445.AM2015-LB-005

Amini A; Masoumi-Moghaddam S; Ehteda A; Liauw W; Akhter J; Pilai K; Morris DL, 2015, 'Synergistic inhibition of human gastric and colorectal cancers by Bromelain and N-acetylcysteine: An in vivo study', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, PA, Philadelphia, Vol. 75, presented at 106th Annual Meeting of the American-Association-for-Cancer-Research (AACR), PA, Philadelphia, 18 April 2015 - 22 April 2015, http://dx.doi.org/10.1158/1538-7445.AM2015-LB-007

Amini A; Masoumi-Moghaddam S; Morris DL, 2015, 'BROMELAIN AND N-ACETYLCYSTEINE INHIBIT PROLIFERATION AND SURVIVAL OF GASTROINTESTINAL CANCER CELLS: SIGNIFICANCE OF COMBINATION THERAPY', in ANNALS OF ONCOLOGY, OXFORD UNIV PRESS, FRANCE, Paris, Vol. 26, pp. 27 - 27, presented at 13th International Congress on Targeted Anticancer Therapies (TAT), FRANCE, Paris, 02 March 2015 - 04 March 2015, http://dx.doi.org/10.1093/annonc/mdv094.6

Amini A; Masoumi-Moghaddam S; Morris DL, 2015, 'IN VIVO ASSESSMENT OF GROWTH-INHIBITORY AND MUCIN-DEPLETING EFFECTS OF BROMELAIN AND N-ACETYLCYSTEINE IN PERITONEAL CARCINOMATOSIS MODELS', in ANNALS OF ONCOLOGY, OXFORD UNIV PRESS, FRANCE, Paris, Vol. 26, pp. 28 - 28, presented at 13th International Congress on Targeted Anticancer Therapies (TAT), FRANCE, Paris, 02 March 2015 - 04 March 2015, http://dx.doi.org/10.1093/annonc/mdv095.3

Masoumi-Moghaddam S; Amini A; Morris DL, 2015, 'SPROUTY 2 PROTEIN, BUT NOT SPROUTY 4, IS AN INDEPENDENT PROGNOSTIC BIOMARKER FOR HUMAN EPITHELIAL OVARIAN CANCER', in ANNALS OF ONCOLOGY, OXFORD UNIV PRESS, FRANCE, Paris, Vol. 26, pp. 22 - 22, presented at 13th International Congress on Targeted Anticancer Therapies (TAT), FRANCE, Paris, 02 March 2015 - 04 March 2015, http://dx.doi.org/10.1093/annonc/mdv092.4

Pillai K; Alalem I; Akhter J; Chua TC; Shehata M; Morris DL, 2014, 'EFFECT OF NON-PARALLEL PLACEMENT OF INCIRCLE BIPOLAR RADIOFREQUENCY ABLATION PROBES ON VOLUME OF TISSUE ABLATED WITH HEAT SINK', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, Vol. 50, pp. E65 - E65, http://dx.doi.org/10.1016/j.ejca.2014.03.246

Patents

Akhter J; Morris D; Pillai K; Aston R, 2022, Treatment of diseases involving mucin, Patent No. United States 11369666

Pillai K; Morris D; Akhter J; Aston R, 2019, Treatment of diseases involving mucin, Patent No. Denmark patent no. 2931296; Hong Kong patent no. HK1211213, https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160520&DB=&locale=en_EP&CC=HK&NR=1211213A1&KC=A1&ND=4

Morris DL, 1997, Method and apparatus for the prevention of venous thrombosis, Patent No.

Morris DL, 1997, Method of treatment of Hepatoma and Pharmaceutical Compositions for use therein, Patent No.

Morris DL, 1997, Use of tumor associated Glycoproteins in transplantation, Patent No.

Preprints

Farrell R; Liauw W; Morris D, 2022, Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian cancer in an Australian institution: Lessons from 20 years experience, , http://dx.doi.org/10.21203/rs.3.rs-1773366/v1

Farrell R; Liauw W; Morris D, 2022, Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian cancer in an Australian institution: Lessons from 20 years' experience, , http://dx.doi.org/10.21203/rs.3.rs-1773366/v2

Mekkawy AH; Pillai K; Suh H; Badar S; Akhter J; Kepenekian V; Ke K; Valle SJ; Morris DL, 2021, Bromelain and acetylcysteine (BromAc (R)) alone and in combination with gemcitabine inhibit subcutaneous deposits of pancreatic cancer after intraperitoneal injection, , https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000740417800011&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Pillai K; Mekkawy A; Akhter J; Valle S; Morris D, 2021, Effect of nebulised BromAc^® on rheology of artificial sputum: relevance to muco-obstructive respiratory diseases including COVID-19, , http://dx.doi.org/10.1101/2021.12.28.474344

Coelho dos Reis JG; Ferreira GM; Lourenço AA; Ribeiro ÁL; Martins da Mata CPDS; de Melo Oliveira P; de Almeida Marques DP; Ferreira LL; Clarindo FA; da Silva MF; Póvoas Filho HP; Oliveira Junior NRR; D’Carmo Sodré MM; Gadelha SR; Albuquerque GR; Maciel BM; Melo Mariano AP; de Melo Silva M; Fontana R; Marin LJ; Alberto Carlos RS; Sampaio Lopes AT; Ferreira FB; dos Santos UR; de Santana ÍTS; Fehlberg HF; Rezende RP; Dias JC; Gross E; Castro Goulart GA; Santiago MG; de Lemos APML; da Conceição A; Romano CC; de Carvalho LD; Martins Filho OA; Quadros CA; Valle S; Morris D, 2021, Ex-vivo mucolytic and anti-inflammatory activity of BromAc in tracheal aspirates from COVID-19, , http://dx.doi.org/10.1101/2021.12.23.21268347

Bhatt A; Rousset P; Baratti D; Biacchi D; Benzerdjeb N; Hingh ID; Deraco M; Gushcin V; Kammar P; Labow D; Levine E; Moran B; Mohamed F; Morris D; Mehta S; Nissan A; Alyami M; Adileh M; Barat S; Yacov AB; Campbell K; Cummins-Perry K; Cortes-Guiral D; Cohen N; Parikh L; Alammari S; Bashanfer G; Alshukami A; Kundalia K; Goswami G; Van de Vlasakker V; Sittig M; Sammartino P; Sardi A; Villeneuve L; Turaga K; Yonemura Y; Glehen O, 2021, Patterns of peritoneal dissemination and response to systemic chemotherapy in common and rare peritoneal tumors treated by cytoreductive surgery: Study protocol of a prospective, multi-center, observational study, , http://dx.doi.org/10.1101/2021.04.01.21254760

Other

Meagher NS; Gorringe KL; Wakefield M; Bolithon A; Pang CNI; Chiu DS; Anglesio MS; Mallitt K-A; Doherty JA; Harris HR; Schildkraut JM; Berchuck A; Cushing-Haugen KL; Chezar K; Chou A; Tan A; Alsop J; Barlow E; Beckmann MW; Boros J; Bowtell DDL; Brand AH; Brenton JD; Campbell I; Cheasley D; Cohen J; Cybulski C; Elishaev E; Erber R; Farrell R; Fischer A; Fu Z; Gilks B; Gill AJ; Gourley C; Grube M; Harnett PR; Hartmann A; Hettiaratchi A; Høgdall CK; Huzarski T; Jakubowska A; Jimenez-Linan M; Kennedy CJ; Kim B-G; Kim J-W; Kim J-H; Klett K; Koziak JM; Lai T; Laslavic A; Lester J; Leung Y; Li N; Liauw W; Lim BWX; Linder A; Lubiński J; Mahale S; Mateoiu C; McInerny S; Menkiszak J; Minoo P; Mittelstadt S; Morris D; Orsulic S; Park S-Y; Pearce CL; Pearson JV; Pike MC; Quinn CM; Mohan GR; Rao J; Riggan MJ; Ruebner M; Salfinger S; Scott CL; Shah M; Steed H; Stewart CJR; Subramanian D; Sung S; Tang K; Timpson P; Ward RL; Wiedenhoefer R; Thorne H; Cohen PA; Crowe P; Fasching PA; Gronwald J; Hawkins NJ; Høgdall E; Huntsman DG; James PA; Karlan BY; Kelemen LE; Kommoss S; Konecny GE; Modugno F; Park SK; Staebler A; Sundfeldt K; Wu AH; Talhouk A; Pharoah PDP; Anderson L; DeFazio A; Köbel M; Friedlander ML; Ramus SJ, 2023, Data from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes, , http://dx.doi.org/10.1158/1078-0432.c.6532782

Meagher NS; Gorringe KL; Wakefield M; Bolithon A; Pang CNI; Chiu DS; Anglesio MS; Mallitt K-A; Doherty JA; Harris HR; Schildkraut JM; Berchuck A; Cushing-Haugen KL; Chezar K; Chou A; Tan A; Alsop J; Barlow E; Beckmann MW; Boros J; Bowtell DDL; Brand AH; Brenton JD; Campbell I; Cheasley D; Cohen J; Cybulski C; Elishaev E; Erber R; Farrell R; Fischer A; Fu Z; Gilks B; Gill AJ; Gourley C; Grube M; Harnett PR; Hartmann A; Hettiaratchi A; Høgdall CK; Huzarski T; Jakubowska A; Jimenez-Linan M; Kennedy CJ; Kim B-G; Kim J-W; Kim J-H; Klett K; Koziak JM; Lai T; Laslavic A; Lester J; Leung Y; Li N; Liauw W; Lim BWX; Linder A; Lubiński J; Mahale S; Mateoiu C; McInerny S; Menkiszak J; Minoo P; Mittelstadt S; Morris D; Orsulic S; Park S-Y; Pearce CL; Pearson JV; Pike MC; Quinn CM; Mohan GR; Rao J; Riggan MJ; Ruebner M; Salfinger S; Scott CL; Shah M; Steed H; Stewart CJR; Subramanian D; Sung S; Tang K; Timpson P; Ward RL; Wiedenhoefer R; Thorne H; Cohen PA; Crowe P; Fasching PA; Gronwald J; Hawkins NJ; Høgdall E; Huntsman DG; James PA; Karlan BY; Kelemen LE; Kommoss S; Konecny GE; Modugno F; Park SK; Staebler A; Sundfeldt K; Wu AH; Talhouk A; Pharoah PDP; Anderson L; DeFazio A; Köbel M; Friedlander ML; Ramus SJ, 2023, Data from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes, , http://dx.doi.org/10.1158/1078-0432.c.6532782.v1

Meagher NS; Gorringe KL; Wakefield M; Bolithon A; Pang CNI; Chiu DS; Anglesio MS; Mallitt K-A; Doherty JA; Harris HR; Schildkraut JM; Berchuck A; Cushing-Haugen KL; Chezar K; Chou A; Tan A; Alsop J; Barlow E; Beckmann MW; Boros J; Bowtell DDL; Brand AH; Brenton JD; Campbell I; Cheasley D; Cohen J; Cybulski C; Elishaev E; Erber R; Farrell R; Fischer A; Fu Z; Gilks B; Gill AJ; Gourley C; Grube M; Harnett PR; Hartmann A; Hettiaratchi A; Høgdall CK; Huzarski T; Jakubowska A; Jimenez-Linan M; Kennedy CJ; Kim B-G; Kim J-W; Kim J-H; Klett K; Koziak JM; Lai T; Laslavic A; Lester J; Leung Y; Li N; Liauw W; Lim BWX; Linder A; Lubiński J; Mahale S; Mateoiu C; McInerny S; Menkiszak J; Minoo P; Mittelstadt S; Morris D; Orsulic S; Park S-Y; Pearce CL; Pearson JV; Pike MC; Quinn CM; Mohan GR; Rao J; Riggan MJ; Ruebner M; Salfinger S; Scott CL; Shah M; Steed H; Stewart CJR; Subramanian D; Sung S; Tang K; Timpson P; Ward RL; Wiedenhoefer R; Thorne H; Cohen PA; Crowe P; Fasching PA; Gronwald J; Hawkins NJ; Høgdall E; Huntsman DG; James PA; Karlan BY; Kelemen LE; Kommoss S; Konecny GE; Modugno F; Park SK; Staebler A; Sundfeldt K; Wu AH; Talhouk A; Pharoah PDP; Anderson L; DeFazio A; Köbel M; Friedlander ML; Ramus SJ, 2023, Supplementary Figures S1-S13 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes, , http://dx.doi.org/10.1158/1078-0432.22488654

Meagher NS; Gorringe KL; Wakefield M; Bolithon A; Pang CNI; Chiu DS; Anglesio MS; Mallitt K-A; Doherty JA; Harris HR; Schildkraut JM; Berchuck A; Cushing-Haugen KL; Chezar K; Chou A; Tan A; Alsop J; Barlow E; Beckmann MW; Boros J; Bowtell DDL; Brand AH; Brenton JD; Campbell I; Cheasley D; Cohen J; Cybulski C; Elishaev E; Erber R; Farrell R; Fischer A; Fu Z; Gilks B; Gill AJ; Gourley C; Grube M; Harnett PR; Hartmann A; Hettiaratchi A; Høgdall CK; Huzarski T; Jakubowska A; Jimenez-Linan M; Kennedy CJ; Kim B-G; Kim J-W; Kim J-H; Klett K; Koziak JM; Lai T; Laslavic A; Lester J; Leung Y; Li N; Liauw W; Lim BWX; Linder A; Lubiński J; Mahale S; Mateoiu C; McInerny S; Menkiszak J; Minoo P; Mittelstadt S; Morris D; Orsulic S; Park S-Y; Pearce CL; Pearson JV; Pike MC; Quinn CM; Mohan GR; Rao J; Riggan MJ; Ruebner M; Salfinger S; Scott CL; Shah M; Steed H; Stewart CJR; Subramanian D; Sung S; Tang K; Timpson P; Ward RL; Wiedenhoefer R; Thorne H; Cohen PA; Crowe P; Fasching PA; Gronwald J; Hawkins NJ; Høgdall E; Huntsman DG; James PA; Karlan BY; Kelemen LE; Kommoss S; Konecny GE; Modugno F; Park SK; Staebler A; Sundfeldt K; Wu AH; Talhouk A; Pharoah PDP; Anderson L; DeFazio A; Köbel M; Friedlander ML; Ramus SJ, 2023, Supplementary Figures S1-S13 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes, , http://dx.doi.org/10.1158/1078-0432.22488654.v1

Meagher NS; Gorringe KL; Wakefield M; Bolithon A; Pang CNI; Chiu DS; Anglesio MS; Mallitt K-A; Doherty JA; Harris HR; Schildkraut JM; Berchuck A; Cushing-Haugen KL; Chezar K; Chou A; Tan A; Alsop J; Barlow E; Beckmann MW; Boros J; Bowtell DDL; Brand AH; Brenton JD; Campbell I; Cheasley D; Cohen J; Cybulski C; Elishaev E; Erber R; Farrell R; Fischer A; Fu Z; Gilks B; Gill AJ; Gourley C; Grube M; Harnett PR; Hartmann A; Hettiaratchi A; Høgdall CK; Huzarski T; Jakubowska A; Jimenez-Linan M; Kennedy CJ; Kim B-G; Kim J-W; Kim J-H; Klett K; Koziak JM; Lai T; Laslavic A; Lester J; Leung Y; Li N; Liauw W; Lim BWX; Linder A; Lubiński J; Mahale S; Mateoiu C; McInerny S; Menkiszak J; Minoo P; Mittelstadt S; Morris D; Orsulic S; Park S-Y; Pearce CL; Pearson JV; Pike MC; Quinn CM; Mohan GR; Rao J; Riggan MJ; Ruebner M; Salfinger S; Scott CL; Shah M; Steed H; Stewart CJR; Subramanian D; Sung S; Tang K; Timpson P; Ward RL; Wiedenhoefer R; Thorne H; Cohen PA; Crowe P; Fasching PA; Gronwald J; Hawkins NJ; Høgdall E; Huntsman DG; James PA; Karlan BY; Kelemen LE; Kommoss S; Konecny GE; Modugno F; Park SK; Staebler A; Sundfeldt K; Wu AH; Talhouk A; Pharoah PDP; Anderson L; DeFazio A; Köbel M; Friedlander ML; Ramus SJ, 2023, Supplementary Methods 1 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes, , http://dx.doi.org/10.1158/1078-0432.22488651.v1

Meagher NS; Gorringe KL; Wakefield M; Bolithon A; Pang CNI; Chiu DS; Anglesio MS; Mallitt K-A; Doherty JA; Harris HR; Schildkraut JM; Berchuck A; Cushing-Haugen KL; Chezar K; Chou A; Tan A; Alsop J; Barlow E; Beckmann MW; Boros J; Bowtell DDL; Brand AH; Brenton JD; Campbell I; Cheasley D; Cohen J; Cybulski C; Elishaev E; Erber R; Farrell R; Fischer A; Fu Z; Gilks B; Gill AJ; Gourley C; Grube M; Harnett PR; Hartmann A; Hettiaratchi A; Høgdall CK; Huzarski T; Jakubowska A; Jimenez-Linan M; Kennedy CJ; Kim B-G; Kim J-W; Kim J-H; Klett K; Koziak JM; Lai T; Laslavic A; Lester J; Leung Y; Li N; Liauw W; Lim BWX; Linder A; Lubiński J; Mahale S; Mateoiu C; McInerny S; Menkiszak J; Minoo P; Mittelstadt S; Morris D; Orsulic S; Park S-Y; Pearce CL; Pearson JV; Pike MC; Quinn CM; Mohan GR; Rao J; Riggan MJ; Ruebner M; Salfinger S; Scott CL; Shah M; Steed H; Stewart CJR; Subramanian D; Sung S; Tang K; Timpson P; Ward RL; Wiedenhoefer R; Thorne H; Cohen PA; Crowe P; Fasching PA; Gronwald J; Hawkins NJ; Høgdall E; Huntsman DG; James PA; Karlan BY; Kelemen LE; Kommoss S; Konecny GE; Modugno F; Park SK; Staebler A; Sundfeldt K; Wu AH; Talhouk A; Pharoah PDP; Anderson L; DeFazio A; Köbel M; Friedlander ML; Ramus SJ, 2023, Supplementary Methods 1 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes, , http://dx.doi.org/10.1158/1078-0432.22488651

Meagher NS; Gorringe KL; Wakefield M; Bolithon A; Pang CNI; Chiu DS; Anglesio MS; Mallitt K-A; Doherty JA; Harris HR; Schildkraut JM; Berchuck A; Cushing-Haugen KL; Chezar K; Chou A; Tan A; Alsop J; Barlow E; Beckmann MW; Boros J; Bowtell DDL; Brand AH; Brenton JD; Campbell I; Cheasley D; Cohen J; Cybulski C; Elishaev E; Erber R; Farrell R; Fischer A; Fu Z; Gilks B; Gill AJ; Gourley C; Grube M; Harnett PR; Hartmann A; Hettiaratchi A; Høgdall CK; Huzarski T; Jakubowska A; Jimenez-Linan M; Kennedy CJ; Kim B-G; Kim J-W; Kim J-H; Klett K; Koziak JM; Lai T; Laslavic A; Lester J; Leung Y; Li N; Liauw W; Lim BWX; Linder A; Lubiński J; Mahale S; Mateoiu C; McInerny S; Menkiszak J; Minoo P; Mittelstadt S; Morris D; Orsulic S; Park S-Y; Pearce CL; Pearson JV; Pike MC; Quinn CM; Mohan GR; Rao J; Riggan MJ; Ruebner M; Salfinger S; Scott CL; Shah M; Steed H; Stewart CJR; Subramanian D; Sung S; Tang K; Timpson P; Ward RL; Wiedenhoefer R; Thorne H; Cohen PA; Crowe P; Fasching PA; Gronwald J; Hawkins NJ; Høgdall E; Huntsman DG; James PA; Karlan BY; Kelemen LE; Kommoss S; Konecny GE; Modugno F; Park SK; Staebler A; Sundfeldt K; Wu AH; Talhouk A; Pharoah PDP; Anderson L; DeFazio A; Köbel M; Friedlander ML; Ramus SJ, 2023, Supplementary Tables S1-S11 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes, , http://dx.doi.org/10.1158/1078-0432.22488645.v1

Meagher NS; Gorringe KL; Wakefield M; Bolithon A; Pang CNI; Chiu DS; Anglesio MS; Mallitt K-A; Doherty JA; Harris HR; Schildkraut JM; Berchuck A; Cushing-Haugen KL; Chezar K; Chou A; Tan A; Alsop J; Barlow E; Beckmann MW; Boros J; Bowtell DDL; Brand AH; Brenton JD; Campbell I; Cheasley D; Cohen J; Cybulski C; Elishaev E; Erber R; Farrell R; Fischer A; Fu Z; Gilks B; Gill AJ; Gourley C; Grube M; Harnett PR; Hartmann A; Hettiaratchi A; Høgdall CK; Huzarski T; Jakubowska A; Jimenez-Linan M; Kennedy CJ; Kim B-G; Kim J-W; Kim J-H; Klett K; Koziak JM; Lai T; Laslavic A; Lester J; Leung Y; Li N; Liauw W; Lim BWX; Linder A; Lubiński J; Mahale S; Mateoiu C; McInerny S; Menkiszak J; Minoo P; Mittelstadt S; Morris D; Orsulic S; Park S-Y; Pearce CL; Pearson JV; Pike MC; Quinn CM; Mohan GR; Rao J; Riggan MJ; Ruebner M; Salfinger S; Scott CL; Shah M; Steed H; Stewart CJR; Subramanian D; Sung S; Tang K; Timpson P; Ward RL; Wiedenhoefer R; Thorne H; Cohen PA; Crowe P; Fasching PA; Gronwald J; Hawkins NJ; Høgdall E; Huntsman DG; James PA; Karlan BY; Kelemen LE; Kommoss S; Konecny GE; Modugno F; Park SK; Staebler A; Sundfeldt K; Wu AH; Talhouk A; Pharoah PDP; Anderson L; DeFazio A; Köbel M; Friedlander ML; Ramus SJ, 2023, Supplementary Tables S1-S11 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes, , http://dx.doi.org/10.1158/1078-0432.22488645

Back to profile page